Abstract
The present invention is directed to methods and kits useful for diagnosis and/or prognosis of urothelial cancer in a subject. The present invention further relates to methods of assessing severity of cancer and methods of determining efficacy of a treatment for cancer. The methods and kits of the invention comprise determining the levels of semaphorin 3A in a biological sample of a subject.
| Original language | American English |
|---|---|
| Patent number | US2016299142 |
| IPC | G01N 33/ 574 A I |
| Priority date | 2/12/14 |
| State | Published - 13 Oct 2016 |
